جستجوی استاد راهنمای دانشگاهی

Professor Arthur Kaser is a leading academic gastroenterologist and Professor of Gastroenterology at the University of Cambridge. He leads the Gastrointestinal Diseases theme of the NIHR Cambridge Biomedical Research Centre, a partnership between Cambridge University Hospitals and the University of Cambridge. Department of Medicine Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID) British Society for Immunology Funding Recipient His groundbreaking research focuses on the mechanisms of Inflammatory Bowel Disease (IBD) , including: Dysregulation of enterocyte cell intrinsic processes causing IBD Genetic polymorphisms linked to disease risk Purine nucleoside metabolism and unfolded protein response Mitochondrial metabolism in immune regulation Role of GPR35 and ORMDL proteins in epithelial homeostasis Recent publications highlight his work across genetic models, metabolic pathways, and clinical trials in IBD, with a focus on: AAV8 gene therapy for mitochondrial disorders ER stress and autophagy in intestinal epithelium Anti-IL-23 therapies (mirikizumab, risankizumab) Polyunsaturated fatty acids in Crohn's disease pathogenesis Scientific honors include: Fellow of the Academy of Medical Sciences (FMedSci) Fellow of the Royal Society (FRS) He collaborates with clinicians and researchers including Dr. James Lee, Dr. Nicole Kaneider, Dr. Trevor Lawley , and Professor Gordon Dougan. His work is supported by the Medical Research Council and institutional grants from the NIHR Cambridge Biomedical Research Centre.

• Inflammatory Bowel Disease (IBD)
• Gastroenterology
• Immunology
• +۵ مورد دیگر

Wes Robertson is a Researcher at the MRC Laboratory of Molecular Biology (MRC-LMB) , affiliated with the University of Cambridge under the PNAC division. His work bridges Synthetic Biology and Genome Engineering , focusing on reprogramming gut microbiomes through novel genetic tools. His research emphasizes de novo synthesis of bacterial genomes , particularly non-model gut bacteria, to create orthogonal genetic communication systems that enhance biosecurity and stability. Key contributions include pioneering work on recoded E. coli and sense codon reassignment for viral resistance and programmable biotherapeutics. Recent publications highlight advancements in genetic code refactoring , bidirectional genetic isolation , and encoded polymer synthesis , reflecting his long-term vision of deploying synthetic cellular communities to interrogate human health. His lab collaborates on engineering bacteria for disease-responsive therapies. Group Members : Gonzalo Mendoza Ochoa Dhriti Rao

• Synthetic Biology
• Genome Engineering
• Microbiome Reprogramming
• +۲ مورد دیگر

Professor Thuy Do holds the position of Professor of Molecular Microbiology at the University of Leeds School of Dentistry. She specializes in bacteriology, oral biofilms, and microbiome analysis using advanced sequencing technologies. Her research focuses on understanding oral microbiome dysbiosis, host-microbiome interactions, and developing diagnostic tools for systemic diseases linked to oral health. Education: She earned a Licence es Sciences from the Université de Strasbourg (1998), followed by BSc and MSc degrees from Teesside University (1999–2000) and a PhD in Bioprocess Development from De Montfort University (2004). She held a Postdoctoral Research Associate position at King’s College London before joining Leeds in 2012 as a Lecturer in Microbiology. Research Interests: Prof. Do’s work investigates oral microbiota diversity, functional biology of biofilms, and applications of metagenomics/RNA-Seq. Key projects include studying rheumatoid arthritis links to oral dysbiosis, root caries mechanisms, and developing microbiome-based therapies. She also explores antimicrobial materials and regenerative endodontics. Editorial & Leadership: She serves as Associate Editor for multiple journals including Oral Diseases and Frontiers in Oral Health. She chairs IADR committees on new investigator awards and science communication. Her work bridges dental microbiology with systemic health, emphasizing interdisciplinary collaboration. Advising & Training: Supervises postgraduate students in microbiology and dentistry. Teaches Microbiology modules to dental undergraduates. Active in mentoring early-career researchers through editorial roles and conference initiatives.

• Bacteriology
• Microbial Culturing Methods
• Oral Biofilms
• +۶ مورد دیگر

Dr. David Sumpton serves as an Honorary Senior Lecturer within the School of Cancer Sciences at the University of Glasgow, affiliated with the CRUK Scotland Institute in Glasgow. His research bridges cancer biology, metabolism, and therapeutic development, with particular focus on mitochondrial function in malignancies. His research interests center on cancer metabolism , especially mitochondrial pathways driving tumor progression and metastasis. Key areas include nucleotide metabolism (uridine phosphorylase), folate cycle regulation in leukemia, lipid signaling in metastatic niches, and immunometabolism interactions. His work demonstrates how metabolic rewiring enables immune evasion, metastatic colonization, and therapeutic resistance across prostate cancer, leukemia, and solid tumors. Analysis of his 2023-2025 publications reveals strong emphasis on metabolic vulnerabilities for therapeutic targeting, including drug repurposing (lomerizine for CML), mitochondrial DNA mutations enhancing immunotherapy response, and nutrient transporter dependencies (SLC7A5). His team frequently employs multi-omics approaches to stratify cancer subtypes and identify biomarker-driven treatments. While no formal advising or grant information is publicly documented, his collaborative publications across Nature journals, Science Translational Medicine, and Cell Biology indicate extensive institutional partnerships. His lab appears focused on translating metabolic discoveries into preclinical therapeutic strategies, particularly for treatment-resistant cancers. Dr. Sumpton maintains active research in tumor microenvironment dynamics, with recent work on extracellular vesicle-mediated metastatic niche formation and senescence-induced multi-organ dysfunction. His team utilizes physiological cell culture models to improve metabolic fidelity in cancer research.

• Cancer Metabolism
• Mitochondrial Biology
• Leukemia Research
• +۳ مورد دیگر

Professor Owen J Sansom serves as the Director of the Institute of Cancer Sciences at the CRUK Scotland Institute, affiliated with the University of Glasgow. His research primarily focuses on colorectal cancer, particularly the role of the Apc gene and Wnt signalling in intestinal tumorigenesis. He employs inducible mouse models to study early neoplastic changes, aiming to identify novel therapeutic targets and biomarkers. Key research interests include: colorectal cancer mechanisms, Wnt pathway dysregulation, tumor suppressor functions, pancreatic and liver malignancies, cancer metabolism, and the tumor microenvironment. His work integrates molecular biology, genetics, and preclinical modeling to address therapy resistance and metastasis. Professor Sansom leads several research groups at the Beatson Institute, specializing in Pancreatic, Colorectal/Lower GI/Intestinal/Gut Microbiome, and Liver cancers. His team collaborates extensively on projects involving cancer heterogeneity, immune modulation, and precision oncology.

• Colorectal Cancer
• Wnt Signalling
• Tumor Suppressor Genes
• +۳ مورد دیگر

Dr. Brian Ferguson is a Professor and Principal Investigator at the Cambridge Immunology Network and affiliated with the Department of Pathology at the University of Cambridge. His research program focuses on understanding the fundamental mechanisms of innate immunity, particularly in the context of viral infections and vaccine development. Dr. Ferguson's research interests encompass several critical areas of immunological investigation: Mechanisms of pathogen detection by the innate immune system DNA sensing pathways and interferon production Poxvirus immune evasion strategies Vaccinology and vaccine optimization Host-pathogen molecular interactions Role of self and foreign DNA in immune activation Analysis of Dr. Ferguson's recent publications (2021-2025) reveals a consistent research trajectory focused on understanding how viruses interact with host immune sensing mechanisms. His work demonstrates particular expertise in poxviruses (especially vaccinia virus) and their sophisticated immune evasion tactics. A notable trend across his recent work is the exploration of DNA-PK's critical role in viral DNA sensing and immune evasion, alongside investigations into MDA5 variants, TLR21 function in avian species, and the gut-lung immunity axis. His research bridges fundamental immunological mechanisms with translational applications for vaccine development. Dr. Ferguson's laboratory has made significant contributions to understanding: The molecular mechanisms by which DNA activates innate immune responses How viral proteins specifically target host signaling pathways like NF-κB The complex relationship between viral infection, DNA damage response, and immune activation Comparative immunology across different species, particularly avian models The interplay between microbiome composition and vaccine responses As a member of the Cambridge Immunology Network Steering Committee, Dr. Ferguson plays an active role in shaping immunological research directions at Cambridge. His work is supported by major research funding bodies including the Medical Research Council and British Society for Immunology, reflecting the significance and impact of his research in the field of innate immunity and viral pathogenesis.

• Innate Immunity
• Anti-viral Immunity
• Vaccinology
• +۵ مورد دیگر

Dr. Emily Stephenson is a researcher at Newcastle University specializing in immunology, single-cell genomics, and inflammatory disease mechanisms. Her work spans multi-omics analysis of severe diseases, developmental biology, and computational modeling of cellular interactions. Collaborates with leading experts like Professor Muzlifah Haniffa and Professor Christopher Stewart Focuses on T cell dynamics, myeloid interactions, and immune dysfunction in conditions like severe COVID-19 Key contributor to single-cell mapping of human immunity across organs and developmental stages Research Trends: Her recent publications highlight cross-disciplinary studies of immune system behavior in viral infections, inflammatory diseases, and developmental contexts. Sub-fields include spatial cellular mapping, metaplasia mechanisms, and computational modeling of immune-microenvironment interactions. Key Collaborations: Active in large-scale consortia projects like RECOVERY and single-cell atlas initiatives, often integrating multi-omics approaches to study disease pathogenesis and development.

• Immunology
• Single-Cell Genomics
• Inflammatory Diseases
• +۳ مورد دیگر

Islam Abd El-Daim is a Strategic Research Fellow at the Institute of Biological, Environmental & Rural Sciences (IBERS), Aberystwyth University. His research focuses on understanding microbial-mediated stress tolerance mechanisms in plants, particularly leveraging bacterial endophytes to enhance plant resilience under abiotic stresses. Key projects include investigating how halotolerant bacteria like Bacillus velezensis improve stress tolerance in Brachypodium and wheat with minimal transcriptional changes. Current projects include the UKRI-funded initiative 'Role of Perennial Biomass Crops microbiomes in reducing N2O emission' (2024-2025), where he leads efforts to explore plant-microbiome interactions for environmental sustainability. His work aligns with UN Sustainable Development Goals related to climate action and sustainable agriculture. Research outputs include peer-reviewed articles in Frontiers in Plant Science and collaborations on topics like holobiont dynamics and rhizobacterial stress mitigation. Media coverage includes a 2025 feature on his Brachypodium stress tolerance study.

• Plant Science
• Microbiology
• Abiotic Stress Tolerance
• +۴ مورد دیگر

Jaswinder K. Sethi (also known as Jazz Sethi) is a Professor of Immunometabolism at the University of Southampton, Faculty of Medicine. She is also an Honorary NHS Foundation Trust Research Fellow and a member of the Institute for Life Sciences. Her research focuses on the intersection of immunology and metabolism, particularly examining how immune processes influence metabolic functions in obesity and related diseases. As Programme Co-Lead for the Integrated PhD in Biomedical Science, she plays a significant role in shaping graduate education at the university. Professor Sethi received her primary and secondary education in London and graduated with First-Class Honours in Biological Sciences from Birkbeck College, University of London in 1993. Her academic journey continued with: DPhil in physiological sciences from Oxford University (1997), supervised by Antony Galione Postdoctoral training at Harvard University with Gokhan Hotamisligil Establishment of a research group at Cambridge University (2000) Relocation of her laboratory to University of Southampton (2017) Professor Sethi's research interests center on immunometabolism, obesity, and metabolic diseases, with a particular focus on tissue remodelling and disease mechanisms. Her work investigates how adipose tissue biology contributes to systemic metabolic dysfunction, especially in non-alcoholic fatty liver disease (NAFLD). She examines the role of various fatty acids in immune cell function and how these processes contribute to the development of metabolic complications. Her research bridges basic science with clinical applications, seeking to identify novel therapeutic targets for metabolic disorders. Analysis of Professor Sethi's recent publications reveals a strong focus on adipose tissue biology and its relationship with liver disease, particularly NAFLD. Her work frequently examines how adipose tissue fibrogenesis markers correlate with liver fibrosis, and she has conducted clinical trials investigating synbiotic treatments for NAFLD. A recurring theme is the role of growth differentiation factor-15 (GDF-15) in connecting type 2 diabetes with liver fibrosis. Her research increasingly incorporates multi-omics approaches to understand the complex interplay between adipose tissue, gut microbiome, and liver function in metabolic disease. Professor Sethi has received numerous prestigious awards and fellowships throughout her career: Fellow of the Royal Society of Biology (FRSB) Wellcome Trust Career Re-entry Fellow (2017) Honorary NHS Research Fellow (2017) BBSRC David Phillips Research Fellowship (2001) Diabetes UK RD Lawrence Research Fellowship (2001) Wellcome Trust International Prize Travelling Postdoctoral Fellowship (1997) British Fulbright Senior Scholarship (1997) As an active supervisor, Professor Sethi currently mentors seven PhD students across various biomedical programs at the University of Southampton. She serves as Programme Co-Lead for the Integrated PhD in Biomedical Science and is deeply involved in teaching across undergraduate and postgraduate programs. Her research group is part of multiple collaborative networks including the Centre for Human Development, Stem Cells and Regeneration, and the NIHR Southampton Biomedical Research Centre, securing funding from major research councils including BBSRC and MRC. Professor Sethi leads a research group investigating Immunometabolic Signalling in Tissue Remodelling and Metabolic Disease. Her laboratory is part of the Institute for Life Sciences and collaborates closely with the Nutrition, Endocrinology and Metabolism research group. The team employs a multidisciplinary approach combining molecular biology, cell culture techniques including patient-derived organoids, and clinical studies to unravel the complex mechanisms linking immune function with metabolic processes in obesity-related diseases.

• Immunometabolism
• Obesity
• Metabolic diseases
• +۵ مورد دیگر

Karl Hoffmann is a Professor in the Department of Life Sciences at Aberystwyth University, where he leads research in parasitology, focusing on schistosomiasis and other helminth infections. He is a principal investigator in major externally funded projects including WORMVACS2.0 (Horizon Europe), and leads the Barrett Centre for Helminth Control (BCHC), contributing significantly to global efforts against neglected tropical diseases. His research interests lie at the intersection of developmental biology, epigenetics, and gene regulation in parasitic helminths, particularly Schistosoma mansoni . His lab employs both hypothesis-driven and discovery-based strategies to identify new anthelmintic drugs and vaccine candidates. A central theme is leveraging functional genomics and epigenomic tools to uncover vulnerabilities in parasite biology. Analysis of his recent publications reveals a strong trajectory in target-based drug discovery , with a focus on epigenetic regulators such as SmLSD1 and SmBRD3. His work increasingly spans cross-parasite applications , as seen in studies showing anti-malarial activity of anti-schistosomal compounds, and explores host-parasite interactions , including microbiome and immune modulation. His team also contributes to methodological standards, such as guidelines for extracellular vesicle research in helminths. Queen’s Anniversary Prize (2023) Research Prize, Sandler Center for Parasitological Research (2009) Prof. Hoffmann actively supervises postgraduate researchers and collaborates with institutions including the Sanger Institute, Liverpool School of Tropical Medicine, and Leiden University. His work includes advising Public Health Wales on swimmer’s itch and contributing to policy discussions on parasitic disease control. He has led numerous funded projects from Wellcome Trust, Innovate UK, and Life Sciences Research Network Wales, demonstrating sustained research leadership and grant acquisition. He is involved in key research networks such as the Flatworm Functional Genomics Initiative (FUGI) and contributes to community roadmaps for rigorous parasitology research. His lab utilizes advanced imaging, high-throughput screening, and molecular techniques to study parasite viability and phenotype.

• Parasitology
• Helminth Biology
• Developmental Biology
• +۹ مورد دیگر

Amanda Lloyd is a researcher at Aberystwyth University, actively involved in the Metabolomics and Diet and Health Teams. She holds a PhD in Metabolomics and Plant Pathology and has extensive experience in nutritional metabolomics, biomarker discovery, and clinical trial design. Her work spans multiple externally funded projects with UKRI, MRC, Innovate UK, and international collaborators in France, Spain, Canada, and India. Her research focuses on developing and applying metabolomic technologies to identify and validate urinary biomarkers of food intake (BFIs), assess dietary exposure, and link diet to health outcomes. She has developed standardized protocols for nutritional metabolomics and contributed to the chemical phenotyping of plant and animal products. Her expertise includes data integration from dietary self-reports and metabolomic profiles, remote urine sampling, and multivariate modeling. The recent publications highlight a strong trend in functional foods, dietary biomarkers, and metabolic health. Themes include the health effects of tea, ginger, rhubarb, whole grains, and probiotics, assessed through human intervention trials and metabolomic profiling. Research spans cardiometabolic health, gut microbiome, cognitive function, and preconception wellness. She has played leadership roles in major initiatives such as the 'Future Foods' programme and the MRC's 'SODIAT' grant, aimed at creating objective dietary assessment tools. She is Principal Investigator (PI) or Co-Investigator (CoI) on multiple active projects related to functional foods, food innovation, and health assessment. Co-investigator, MRC Programme Grant 'SODIAT' (2022–2027) PI, 'Better Brain DLS' (Innovate UK, 2023–2026) PI, 'Reformulation of multi-component food-items' (University of Bristol, 2024–2025) PI, 'Academic research development to benefit health teas' (BBSRC, 2024) She has supervised PhD research and contributed to the establishment of the Well-being and Health Assessment Research Unit (WARU) at Aberystwyth University, enabling small-scale clinical trials and community health research. Her work supports UN Sustainable Development Goals related to health, well-being, and sustainable food systems.

• Metabolomics
• Nutritional Biomarkers
• Dietary Assessment
• +۷ مورد دیگر

Dr. Johan Vande Voorde is a Senior Research Fellow at the School of Cancer Sciences, University of Glasgow, and Associate Group Leader at the CRUK Scotland Institute. His research focuses on metabolic crosstalk between the host and tumors, with particular emphasis on gut microbiome interactions in cancer and metabolic determinants of cancer-associated cachexia. His educational background includes: PhD, Rega Institute, KU Leuven, Belgium (2013) MSc, Biological Sciences, University of Amsterdam, the Netherlands (2007) Professional Bachelor (Biochemistry), KH Leuven, Belgium (2005) Dr. Vande Voorde's research investigates how cancer cells undergo metabolic rewiring to sustain proliferation and survive in hostile environments. His laboratory specifically examines metabolic interactions between the gut microbiome and host cells in colorectal cancer, and studies the mechanisms underlying cancer-associated cachexia - a wasting syndrome with no current cure. His work utilizes advanced preclinical cancer models and patient samples to identify metabolic vulnerabilities for therapeutic targeting. Analysis of his publication record reveals a strong trajectory in cancer metabolism research, with increasing focus on metabolic profiling, tumor microenvironment interactions, and physiological relevance of cancer models. His recent work demonstrates expertise in spatial metabolomics, amino acid transport mechanisms, and metabolic vulnerabilities across multiple cancer types including colorectal, prostate, and breast cancers. His notable achievements include: Cancer Research UK Career Development Fellowship (2024) Lord Kelvin/Adam Smith Leadership Fellowship, University of Glasgow (2024) PhD fellowship, Government of Flanders (Belgium)-IWT (2009) HSP Huygens scholarship, Nuffic (Netherlands) (2006) Dr. Vande Voorde leads an active research team comprising postdoctoral scientists, a PhD student, and technical staff. His laboratory collaborates extensively with other research groups at the CRUK Scotland Institute, particularly those studying colorectal cancer, pancreatic cancer, and tumor microenvironment. He has secured significant funding through his recent fellowships to advance his research program. The Vande Voorde Laboratory operates within the CRUK Scotland Institute at Garscube Estate in Glasgow. The lab maintains strong connections with Professor Owen Sansom's group and collaborates across multiple research themes including liver cancer, pancreatic cancer, and mitochondrial reprogramming in cancer. His team's work bridges basic cancer metabolism research with potential clinical applications for improving cancer therapy outcomes.

• Cancer Metabolism
• Metabolic Crosstalk
• Gut Microbiome and Cancer
• +۳ مورد دیگر

Dr. Miguel Pineda is a Lecturer in Molecular Biosciences at the University of Glasgow, focusing on immunology and glycobiology in inflammatory diseases. His research explores the role of synovial fibroblasts in rheumatoid arthritis (RA), emphasizing glycan-mediated cell-cell interactions and helminth-derived immunomodulators like ES-62. Medical Research Council Grant (2024-2027): Synovial glycome in inflammation Arthritis Research UK Grant (2016-2021): Targeting glycan pathways in RA Pineda's work reveals how aberrant glycosylation in fibroblasts drives chronic inflammation and how parasitic worm products reset immune homeostasis via microbiome and epigenetic mechanisms. His 2024-2021 studies demonstrate ES-62's microbiome-dependent arthritis protection and metabolic rewiring by propolis extracts. Recent articles highlight trends in glycan immunobiology, helminth therapeutics, and stromal cell inflammation. Key subfields include synovial fibroblast sialylation, TLR4 signaling in lung injury, and microbiome-bone marrow axis modulation. 2024: ES-62 gut-joint axis study 2023: CD20⁺ T-cell inflammatory mechanisms 2021: Apigenin C-glycosides in lung inflammation Pineda supervises researchers like Çağlar Çil and Julia Isakova. His grants from MRC, Cancer Research UK, and Arthritis Research UK fund projects on glycan signatures, 3D fibroblast cultures, and immuno-oncology-arthritis intersections. Collaborations span parasitology, immunology, and metabolomics.

• Immunology
• Glycobiology
• Inflammatory Diseases
• +۲ مورد دیگر

Mei Chen is a Professor at the Wellcome Wolfson Institute for Experimental Medicine within the School of Medicine, Dentistry and Biomedical Sciences at Queen's University Belfast. She maintains an active research program with current projects extending into 2025 and accepts PhD students for research in retinal degeneration and drug delivery. Her research focuses on the immunopathogenesis of age-related retinal degeneration and ocular drug delivery systems. Key areas include investigating inflammation in diabetic retinopathy, the role of Müller cells in the retinal neurovascular unit, and developing topical drug delivery methods for posterior segment eye diseases. Her work establishes critical connections between immune dysfunction and retinal diseases like AMD, diabetic retinopathy, and retinitis pigmentosa. Analysis of her recent publications reveals strong trends in macrophage/microglia biology in retinal fibrosis, metabolic reprogramming approaches to reduce fibrosis, and emerging research on gut-retina axis interactions. Her work consistently bridges fundamental immunology with translational ophthalmology applications. Fight for Sight Early Career Investigator Award (2012) ARVO Annual meeting International Travel Award (2015) ISER International Travel Award (2010) Travel award (IL1 mediated inflammation and diabetes) (2013) Uveitis Award (2nd Prize) (2011) Professor Chen serves as Co-Investigator on multiple major research projects including NIH-funded work on microglia circadian disruption in diabetic retinopathy and macrophage roles in AMD-related fibrosis. She actively mentors students (supervising 13 research projects), performs external PhD examinations, and hosts academic visitors. Her laboratory maintains the QMMuC-1 mouse Müller cell line for studying retinal pathophysiology. The Wellcome Wolfson Institute for Experimental Medicine provides the primary research environment where her team investigates retinal neurovascular units, develops novel drug delivery systems, and explores inflammation mechanisms in retinal degeneration. Current collaborations include University of Birmingham researchers on cell-penetrating peptide drug delivery systems.

• Ophthalmology
• Retinal Degenerative Diseases
• Immunopathogenesis
• +۵ مورد دیگر

Manfred Beckmann is a Research Lecturer and Metabolomics Champion at the Institute of Biological, Environmental and Rural Sciences (IBERS), Aberystwyth University, where he leads the High Resolution Metabolomics Laboratory. His work spans analytical chemistry, metabolomics, and nutritional science, with a focus on developing and applying high-throughput, ultra-high-resolution techniques such as FIE-MS, LC-MS, and GC-tof-MS to study biological systems in plants, animals, and humans. His research interests center on non-targeted metabolomics, signal processing, metabolite identification, and the impact of diet on the plasma and urinary metabolome. He is dedicated to discovering biomarkers of health and wellbeing, particularly in the context of dietary interventions and disease responses. His work contributes to UN Sustainable Development Goals in health, nutrition, and sustainable agriculture. The recent publications reflect a strong trend in applying metabolomics to diverse systems: human nutrition (e.g., tea, rhubarb, supplements), plant stress responses (drought, pathogens), postharvest physiology, and veterinary diagnostics (MAP infection). The integration of machine learning and multi-omics approaches is increasingly evident, highlighting a move toward data-driven, systems-level understanding. Dr. Beckmann is actively involved in externally funded research, including projects with the Medical Research Council and the Welsh Government, focusing on dietary assessment tools, Welsh honey and tea products, and novel food applications. He collaborates widely with clinical, veterinary, and industry partners. He has supervised doctoral researchers such as Baharehsadat Haddadi and contributes to impactful initiatives like 'The Great British Urine Test,' which aims to develop novel health monitoring tools. His laboratory plays a central role in method standardization and robust protocol development to minimize variability in metabolomics data.

• Metabolomics
• Analytical Chemistry
• Metabolite Identification
• +۸ مورد دیگر